| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |